About this event
OSDF remains the most common dosage form developed in the pharmaceutical industry. The opportunities to improve existing formulation or develop new ones request high compendial performant excipients. The objectives are multiple. They can be linked to life cycle management, improvement of patient adhesion or improvement of processes developed at a time where costs were less challenged than nowadays.
In order to give you solutions to address those subjects, Seppic and Shin-Etsu have built this webinar.
Top 4 reasons to attend to discover a multi-talented excipient:
Speaker:
Véronique Henner - Kulkarni
Technical Sales Manager, Shin-Etsu Pharma & Food Materials Distribution GmbH
After her graduation as a pharmacy technician, she joined a German CDMO specialized in solid dosage forms where she gained deeper knowledge in R&D and quality control. Before joining Shin-Etsu she was in charge of the optimization of the production and scale-up/validation. Since 2012 she provides technical support to key account customers as well as distributors in the EMEA area.
Hosted by
An Air Liquide Healthcare company, subsidiary of the Air Liquide group, Seppic has been designing, manufacturing, and marketing unique ingredients for over 75 years. These ingredients are used by consumers, patients, and professionals.
Worldwide, a vast team of talented women and men serve customers
